Thank you Tony, I have the feeling you are well onto the development status. Hopefully PYC respond to understandable investor concerns with an update of the recent comprehensive presentations.
Your identification of the sensitive project factors and the triggers we seek are valuable to the broad crowd of us laymen.
Hopefully there are big pharma interests also Looking forward to more about this body of work. GLTA
Ann: Successful In-vivo Results Peptide Vaccine T-Cell Expansion, page-17
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
0.020(1.59%) |
Mkt cap ! $743.6M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.28 | $1.24 | $46.67K | 37.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15857 | $1.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |